New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth ...

Miscellaneous29.04.2025 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement. Mainz Biomed Enters into Technology Partnership with EDX Medical GroupBERKELEY, US and ...

In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

The global isovaleric acidemia treatment market is poised for remarkable growth, projected to rise from USD 652.28 million in 2023 to USD 1,125.15 million by 2033, reflecting a robust CAGR of 5.6%.

LUND, SE / ACCESS Newswire / April 29, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) will publish the company's interim report for the first quarter of 2025 on Tuesday, May 13, 2025, at 07:00 a.m. CEST.In conjunction to the ...

Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business DaysCritical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner ...

Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the ...

No refractures were reported during long-term follow-up at five yearsAt 24-months post-implantation, 89% of patients achieved bone unionNovadip plans market launch of NVD003 in 2027Mont Saint-Guibert, ...

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...

The global joint replacement market is poised for steady growth, with revenue expected to increase from USD 20.3 billion in 2025 to USD 32.2 billion by 2035, rising at a CAGR of 4.7% over the forecast ...

SHELTON, CT / ACCESS Newswire / April 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum ...